A 28-year-old woman from Mumbai with a 10-year history of atopic dermatitis presents with acute flare-up involving 40% of her body surface area. She has severe pruritus, widespread erythema, and oozing lesions on her face, neck, and trunk. She reports recent emotional stress and discontinuation of her regular moisturizer. On examination, she has excoriation, crusting, and secondary bacterial infection (golden crusts). Her serum IgE is 800 IU/mL. Which of the following is the MOST appropriate first-line management for this acute flare?

Explanation

## Management of Acute Atopic Dermatitis Flare ### Clinical Context **Key Point:** This patient has a moderate-to-severe acute flare (40% BSA involvement) with secondary bacterial infection. Management must address inflammation, pruritus, barrier dysfunction, and infection. ### Stepwise Management Hierarchy ```mermaid flowchart TD A["Acute AD Flare<br/>(40% BSA, oozing, crusting)"]:::outcome --> B{"Assess severity<br/>& infection"}:::decision B -->|"Moderate-severe<br/>+ bacterial signs"| C["Step 1: Emollients<br/>(frequent, liberal)"]:::action C --> D["Step 2: Topical corticosteroids<br/>(potent, e.g., clobetasol)<br/>on inflamed areas"]:::action D --> E{"Bacterial infection<br/>present?"}:::decision E -->|"Yes (golden crusts,<br/>oozing)"| F["Oral antibiotics<br/>(anti-staphylococcal)<br/>+ topical antiseptic"]:::action E -->|"No"| G["Monitor & reassess<br/>in 1–2 weeks"]:::outcome F --> H{"Response<br/>adequate?"}:::decision H -->|"Yes"| I["Continue topical therapy<br/>+ maintenance emollients"]:::action H -->|"No / Severe"| J["Consider systemic<br/>corticosteroids or<br/>calcineurin inhibitors"]:::action ``` ### First-Line Approach: The Stepwise Ladder | Step | Intervention | Indication | Notes | |------|--------------|-----------|-------| | **1** | **Emollients** | All AD patients, all flares | Ceramide-rich, fragrance-free; apply within 3 min of bathing | | **2** | **Topical corticosteroids** | Inflamed areas (erythema, oozing) | Potency matched to severity; face/neck = mild-moderate; trunk = potent | | **3** | **Oral antibiotics** | Secondary bacterial infection | *S. aureus* most common; flucloxacillin or cephalexin | | **4** | **Systemic corticosteroids** | Severe flares failing topical therapy | Short course (7–14 days); taper to avoid rebound | | **5** | **Calcineurin inhibitors** | Steroid-sparing; face/neck (avoid atrophy) | Tacrolimus, pimecrolimus; slower onset than steroids | | **6** | **Phototherapy** | Chronic, maintenance phase | Not first-line for acute flares; requires 2–3 weeks | ### Why This Patient Needs Emollients + Topical Corticosteroids + Antibiotics **High-Yield:** The "itch-scratch-infection" cycle in this case requires: 1. **Emollients** — restore barrier function, reduce TEWL, decrease itch 2. **Topical corticosteroids** — suppress inflammation and pruritus rapidly 3. **Oral antibiotics** — treat/prevent *Staphylococcus aureus* superinfection (evidenced by golden crusts) **Clinical Pearl:** Secondary bacterial infection is common in acute AD flares due to impaired barrier and scratching. Golden crusts, oozing, and pustules warrant anti-staphylococcal coverage (flucloxacillin 500 mg QID or cephalexin 500 mg QID for 7–10 days). ### Why NOT Systemic Corticosteroids as First-Line? **Warning:** Although systemic corticosteroids work quickly, they are NOT first-line for acute flares because: - Topical therapy is often sufficient for localized/moderate flares - Systemic steroids carry risk of rebound flare upon withdrawal - Systemic steroids do not address barrier dysfunction (emollients do) - Reserve systemic steroids for severe, widespread flares failing topical therapy **Tip:** If systemic steroids are used, keep the course short (7–14 days) and taper gradually to avoid rebound. ### Why NOT Calcineurin Inhibitors as First-Line? - Slower onset (2–3 weeks) compared to topical corticosteroids - Useful as **steroid-sparing agents** on face/neck (to avoid skin atrophy) - Better for maintenance, not acute flares - Often used in combination with topical steroids, not as monotherapy ### Why NOT Phototherapy or Immunosuppressants? - **Phototherapy (UVB):** Requires 2–3 weeks for effect; not suitable for acute flares. Reserved for chronic, maintenance phase. - **Immunosuppressants (azathioprine, cyclosporine):** Reserved for severe, refractory AD unresponsive to topical therapy and phototherapy. Not first-line. - **Systemic retinoids:** Not indicated for AD; used in other dermatoses (e.g., severe psoriasis). ### Mnemonic: **BEAT** (Acute AD Flare Management) - **B** — Barrier repair (emollients, ceramides) - **E** — Emollients (frequent, liberal application) - **A** — Anti-inflammatory (topical corticosteroids) - **T** — Treat infection (oral antibiotics if bacterial signs present)